UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: MForion-50mcg-Suspension-SE-IS-RA

Generated Narrative: RegulatedAuthorization MForion-50mcg-Suspension-SE-IS-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/49693

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100000265-00049693,http://ema.europa.eu/fhir/eurdId#2085; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Nasal spray, suspension; indication = Mometason Orion nässpray är avsett för vuxna och barn 3 år och äldre för behandling av symtom vid säsongsbunden allergisk eller perenn rinit. Mometason Orion nässpray är avsett för behandling av näspolyper hos vuxna 18 år och äldre.; legalStatusOfSupply = Medicinal product subject to medical prescription exempt for some pack sizes; classification = R01AD09

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2014-06-26

holder: Organization Orion Corporation

Cases

-TypeDate[x]
*First Authorisation2014-06-26